Corebridge Financial’s Evolent Health EVH Stock Holding History

Corebridge Financial’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-56,557	Closed	-$536K	–	919
2025 Q1	$536K	Sell	56,557 -838	-1%	-$8.46K	﹤0.01%	1552
2024 Q4	$646K	Sell	57,395 -4,332	-7%	-$76.1K	﹤0.01%	1541
2024 Q3	$1.75M	Sell	61,727 -382	-0.6%	-$9.85K	0.01%	1102
2024 Q2	$1.19M	Buy	+62,109	New	+$1.59M	0.01%	1245

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Corebridge Financial's EVH Position: Q2 2025 in Review

Corebridge Financial sold out of Evolent Health (EVH) in Q2 2025, closing a stake of 56,557 shares — an estimated $536K sold.

Corebridge Financial first reported a position in EVH in Q2 2024 and held it in 4 quarters. The position peaked at $1.75M in Q3 2024. 220 funds tracked by Wall St. Rank hold EVH as of Q2 2025.

Corebridge Financial reported no remaining Evolent Health position as of Q2 2025 after selling out during the quarter.
Corebridge Financial sold 56,557 Evolent Health shares in Q2 2025, an estimated $536K.
Corebridge Financial first reported a position in Evolent Health in Q2 2024 and held it in 4 quarters.
Corebridge Financial's Evolent Health position peaked at $1.75M in Q3 2024.
220 funds tracked by Wall St. Rank held Evolent Health as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.